Pablo Silva

Maternal Fetal Medicine, Obstetrics and Gynecology / Hospital Sótero del Rio / PhD (c) in Biomedicine, Universidad de los Andes

[Jezid Miranda, MD, PhD @JezidMiranda]

Nuevo Estudio en @JAMA_current ha puesto en duda la eficacia del sulfato de magnesio para prevenir parálisis cerebral en #prematuros entre las 30 y 34 sem. Contrario a lo esperado, no se observó reducción significativa en mortalidad o parálisis cerebral en niños a los 2 años.🤰🧬

[Beth Allison (she/her) @BethJForbes]

Check out our newest (and first) research paper from @CharmaineRRock showing the progressive decline in cardiovascular function in FGR in the perinatal period. New mechanisms open the way to novel therapeutics? @Hudson_Research @SCSMonash @RitchieCentre

https://t.co/049gNpqpKN

[Pablo Silva @psilvalab]

@nardhygomez @WUSTL @DKhabeleMD @Englandsk785 Congrats Nardhy!! Hope to see you again after my PhD 😊

[Happy Researchers @hapyresearchers]

THE PhD illusion

[AJOG @AJOG_thegray]

AJOG Expert Review in Labor: Uterine-sparing surgical procedures to control postpartum hemorrhage - Tsirulnikov’s triple ligation
Ligation of: (1) uterine arteries, (2) the round ligament, and (3) the utero-ovarian ligaments. https://t.co/5UEbnEWbeI

[AJOG @AJOG_thegray]

Assessing maternal cardiac function by obstetricians: technique and reference ranges - Measurement of the ascending and descending aorta and the velocity time integral https://t.co/7dS7lTMFNo

[El Mercurio @__elmercurio]

Carta al Director | "Revictimización por muerte de un hijo", por María del Pilar Díaz C. https://t.co/uGBl4LaGzo

[Valeria Garcia-Flores @valeriaqbp]

Tackling preterm birth with immune cells? Yes, M2 macrophages are the solution! Learn how these remarkable cells combat sterile inflammation to prevent preterm birth and bolster neonatal immunity. https://t.co/uFzEU0fpFa @nardhygomez’s lab #NGLlab @waynemedicine @NICHD_NIH

[Pablo Silva @psilvalab]

This is the way

[AJOG @AJOG_thegray]

AJOG Expert Review in Labor: Fetal defenses against intrapartum head compression—implications for intrapartum decelerations and hypoxic-ischemic injury https://t.co/iHW9zvggve

[Pablo Silva @psilvalab]

True story #PhD #PhDlife

[Jezid Miranda, MD, PhD @JezidMiranda]

The FDA approval of the angiogenic markers will definitely change the way we predict preeclampsia and stillbirth Worldwide.

Science and clinical practice are not dancing at the same tone, but eventually, they go along.

https://t.co/f3wpGzzli4

[Trends in Molecular Medicine @TrendsMolecMed]

ONLINE NOW: Immunobiology of pregnancy: from basic science to translational medicine https://t.co/Vg9G1gjFG7

[The PhD Place @ThePhDPlace]

10 Things I Wish Someone Had Told Me Before My PhD

Attend conferences and seminars.
Collaborate with others.
Plan your experiments.
Learn new skills

Read more PhD Stories, sponsored by @paperpile
https://t.co/5D6sa9MbyB

[AJOGMFM @ajogmfm]

https://t.co/hLkyaj6L92

[Jezid Miranda, MD, PhD @JezidMiranda]

Paren todo! 🤩 en colaboración con prof. Romero @AJOGEd_RR aplicamos tecnicas moleculares en 692 amniocentesis para responder esta pregunta:
#Lodicho: el líquido AMNIOTICO ES EN ESENCIA ESTERIL, y no existe evidencia d un microbioma antes del nacimiento.
👉https://t.co/P2MPfKdJof

[Pablo Silva @psilvalab]

@nardhygomez @cmmgwsu @larrygrossman @waynemedicine @WSUResearch @waynestate @valeriaqbp @josegalaz @KanninenTomi @ZackShaffer8 @derektm9 I’m in a PhD program now, maybe in a couple of years I could join to work with you

[Jezid Miranda, MD, PhD @JezidMiranda]

📢🚨Alerta! Mujeres q tienen #trombosis venosa superficial durante el #embarazo tienen un 10.4% de riesgo de tener una #TVP en ese embarazo o el postparto.

Ese riesgo justifica TRATAMIENTO d toda Trombosis venosa superficial en🤰🏼- @TheLancetHaem 👉👉

https://t.co/JBmAkczR6g

[Adi Tarca @AdiTarca]

Our paper: "The evolution of the labor curve and its implications for clinical practice: the relationship between cervical dilation, station, and time during labor" is out. Thanks to collaborators Emily Hamilton and Philip Warrick.
https://t.co/6L3CPL9NV6